SCHEMBL6599098

SCHEMBL6599098

COc1ccc(C(=O)N(C)CC(CCN2CCCN(c3nc4ccccc4n3Cc3ccco3)CC2)c2ccc(Cl)c(Cl)c2)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 16/20 0.45
TACR1 P25103 3/20 0.45
TACR3 P29371 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599086 0.91 TACR2 (0.45) TACR2TACR1TACR3
SCHEMBL6598484 0.90 TACR2 (0.45) TACR2TACR1TACR3
SCHEMBL6594052 0.89 TACR2 (0.49) TACR2TACR1
SCHEMBL6593919 0.88 TACR2 (0.47) TACR2TACR1TACR3
SCHEMBL6594022 0.88 TACR2 (0.47) TACR2TACR1TACR3
SCHEMBL6599801 0.88 TACR2 (0.60) TACR2TACR1
SCHEMBL6599798 0.87 TACR2 (0.55) TACR2TACR1
SCHEMBL6597567 0.86 TACR2 (0.43) TACR2TACR1
SCHEMBL7491192 0.86 TACR2 (0.48) TACR2TACR1TACR3
SCHEMBL6597303 0.86 TACR2 (0.54) TACR2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
EP-0888338-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030991-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed